SCHEMBL30539375

SCHEMBL30539375

O=C(NC1CC2(C1)C[C@H]1CC[C@@H](C2)N1)OCc1ccccc1

nearest known ligand 0.57

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 2/20 0.57
GAA P10253 1/20 0.57
TSHR P16473 1/20 0.55
ENPP2 Q13822 1/20 0.53
ATXN2 Q99700 1/20 0.53
EPHX1 P07099 1/20 0.52
ROCK2 O75116 1/20 0.50
CTSL P07711 1/20 0.50
CTSB P07858 1/20 0.50
CTSK P43235 1/20 0.50
CPB1 P15086 2/20 0.47
TLR4 O00206 1/20 0.47
KDM1A O60341 1/20 0.46
MAOB P27338 1/20 0.46
DPP4 P27487 1/20 0.46
KCNH2 Q12809 1/20 0.46
DPP7 Q9UHL4 1/20 0.46
CA1 P00915 1/20 0.46
CA2 P00918 1/20 0.46
ACHE P22303 1/20 0.46

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL19150112 0.84 ALDH1A1 (0.59) ALDH1A1GAATSHRENPP2ATXN2
SCHEMBL19149069 0.84 ALDH1A1 (0.59) ALDH1A1GAATSHRENPP2ATXN2
SCHEMBL31643889 0.84 ALDH1A1 (0.63) ALDH1A1GAATSHREPHX1CTSL
SCHEMBL4315139 0.84 ALDH1A1 (0.63) ALDH1A1GAATSHREPHX1CTSL
SCHEMBL21496920 0.83 ALDH1A1 (0.69) ALDH1A1GAATSHRENPP2ATXN2
SCHEMBL16616249 0.83 ALDH1A1 (0.58) ALDH1A1GAATSHRENPP2ATXN2
SCHEMBL26602184 0.82 ALDH1A1 (0.56) ALDH1A1GAATSHRENPP2ATXN2
SCHEMBL25819454 0.81 ALDH1A1 (0.55) ALDH1A1GAATSHRENPP2ATXN2
SCHEMBL16485927 0.81 ALDH1A1 (0.58) ALDH1A1GAATSHRENPP2ATXN2
SCHEMBL19150130 0.81 ALDH1A1 (0.58) ALDH1A1GAATSHRENPP2ATXN2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-110818704-B Spiro bridged ring compounds, pharmaceutical compositions thereof and uses thereof 广州市恒诺康医药科技有限公司 2023-08-01 CN disclosed